Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates

Overview of attention for article published in Drug Design, Development and Therapy, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 1 news story.

Follow Summary Reata Pharmaceuticals has submitted a New Drug Application to the US Food and Drug Administration for…